| Name | Pegsebrenatide |
|---|
| Description | Pegsebrenatide (NLY01) is a long-acting GLP-1R agonist. Pegsebrenatide has an extended half-life and favorable blood-brain barrier penetration. Pegsebrenatide can block A1 astrocyte transformation, reducing dopaminergic cell death, and improving motor symptoms in mouse models of PD[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C206H318N54O69S2(C2H4O)m+2n; m≈10; n≈20 |
|---|